FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, in particular, to compositions and methods for expression and production of isolated integral membrane proteins (IMP) or fragments thereof in native conformation for application in screening, selection and identification of antibodies or antibody-like molecules binding to the IMP target of interest.
EFFECT: expression and production of IMP is achieved.
34 cl, 10 dwg, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROMOTERS FOR ENHANCING EXPRESSION IN POXVIRUSES | 2016 |
|
RU2753884C2 |
| MULTIVALENT PD-L1-BINDING COMPOUNDS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2816646C2 |
| MODIFIED NON-NATURAL NKG2D LIGANDS WHICH SELECTIVELY DELIVER ATTACHED HETEROLOGOUS MOLECULES TO NON-NATURAL NKG2D RECEPTORS ON CAR CELLS | 2020 |
|
RU2823728C2 |
| HERPES VACCINE | 2019 |
|
RU2731073C1 |
| TREATMENT AND PREVENTION OF ALLERGY TO HOUSE DUST MITES | 2019 |
|
RU2815386C2 |
| BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION | 2019 |
|
RU2764740C1 |
| FUSION POLYPEPTIDE CONTAINING GDF15 AND POLYPEPTIDE REGION CAPABLE OF O-GLYCOSYLATION | 2020 |
|
RU2812049C1 |
| ADENOVIRUSES AND METHODS FOR ADENOVIRUS APPLICATION | 2019 |
|
RU2782528C1 |
| VACCINE COMPOSITION FOR TREATMENT OF CANCER | 2018 |
|
RU2782261C2 |
| RECOVERED NUCLEIC ACID WHICH CODES FVIII-BDD-BASED FUSION PROTEIN AND HETEROLOGOUS SIGNAL PEPTIDE, AND USE THEREOF | 2022 |
|
RU2818229C2 |
